Stellent, Inc. (STEL - $8.59)

Size: px
Start display at page:

Download "Stellent, Inc. (STEL - $8.59)"

Transcription

1 Richard A. Ryan (612) Enterprise Software August 7, 2006 Financial Summary Rev(mil) E Jun $22.3 $28.6 $32.3A Sep $28.0 $30.1 $33.4E Dec $27.7 $31.7 $34.8E Mar $28.5 $33.0 $35.8E FY $106.8 $123.4 $136.2E P/Sales 2.5x 2.2x 2.0x Proforma E EPS Jun $0.01 $0.06 $0.12A Sep $0.06 $0.08 $0.12E Dec $0.04 $0.11 $0.14E Mar $0.04 $0.11 $0.16E FY $0.11 $0.35 $0.54E P/E 78.1x 24.5x 15.9x Price: $ Week Range: $ $7.12 Target: $14.00 Rating: BUY Shares Outstanding: 31.1 mil Mkt. Capitalization: $267 mil Avg. Volume: 207,000 Inst. Ownership: 77% BV / Share: $5.55 Debt / Tot. Cap.: 0% Div./Yield $0.12/1.4% Est. LT EPS Growth: 15%-20% Company Description Stellent, Inc. is a provider of content management software solutions to large companies. Its Universal Content Management software allows companies to manage web content, documents, digital assets, records, and collaboration. Its Contents Components software makes information created in standard office software packages more accessible to its users. Stellent generates about half of its revenue through software license sales, about 35% from maintenance sales, and about 15% from consulting. Stellent, Inc. (STEL - $8.59) Q1 In line/2 Acquisitions Announced. BUY Q1 Results Were In Line With Consensus: For Q1, Stellent reported pro forma EPS of $0.12 on revenue of $32.3 million compared with EPS of $0.06 on $28.6 million.. We had expected pro forma EPS of $0.13 on revenue of $32.8 million. GAAP EPS was $0.07, which included amortization and restructuring charges. In-Line Guidance: Management guided Q2 to $33-$34 million and pro forma EPS of $ $0.12. This guidance surrounds our previous revenue estimate of $33.3 million, but the EPS guidance was lower than our $0.14 estimate. STEL made two acquisitions during Q2 which could dilute FY07 results by $0.03 in Q2 and $0.02 in Q3. An Acquisitive Quarter: On June 29, STEL acquired Bitform, a provider of content cleansing technologies for $2.5 million. On July 31, STEL acquired SealedMedia Limited, a leader in easy-to-use, enterprise digital rights management solutions, for $15 million. These technologies will enable customers to better secure and control sensitive content both inside and outside of the enterprise. Margins are Expanding: Due to the acquisitions, management lowered its operating margin target in 2007 from 14% (non-gaap) to 11%-12%. However, management again indicated that operating margins can be 18%-20% over the next 6-8 quarters. Q1 operating margin of 8.7% represents the third straight quarter over 8%. The mix of license revenue to total revenue is important as this segment generates high gross profit. Management has targeted license revenue to be about 46%-48% of revenue in For Q1, license revenue was 44% of revenue. STEL maintains a strong balance sheet: Cash increased to $84.0 million, generating $3.4 million in cash from operations. Deferred revenue was $21.7 million, up from $21.2 million in Q4. Making Adjustments to Estimates: For revenues, we are maintaining our Q2 estimate, but we are increasing our Q3 estimate by $900K to $34.8 million and our Q4 estimate by $1.4 million to $45.8 million. Our new 2007 revenue estimate is $136.2 million, up from $134.5 million. For EPS, we are reducing our Q2 (per guidance) to $0.12 from $0.14. Our Q3 estimate remains at $0.14 and we are increasing our Q4 estimate by $0.01 to $0.16. Our 2007 EPS estimate is $0.54, down from $0.56. We are introducing estimates for FY 2008 of $149.8 million in revenues and $0.68 per share in earnings. Investment Recommendation: We are impressed with management s conviction to cost containment and driving operating margins higher. With new compliance regulations emerging in Japan, Canada, and Europe, and Stellent s multiple global alliances, we believe leverage exists to our previous estimates. The weakness in the stock most likely reflects the near-term dilutive effects of the acquisitions. We are maintaining our price target of $14. This represents 17x our fiscal 2008 EPS estimate of $0.68, plus cash. This multiple approximates our estimated EPS growth rate for STEL. While STEL s relative valuations appear higher-than-average in the content management space, Stellent also seems positioned to grow its profits and cash flows faster than its peers. In addition, consolidation within the industry is active, and a premium-priced acquisition for STEL is always a possibility. Feltl and Company Research Department. Please see important disclosures on pages 3 to South Sixth Street, Suite 4200 Minneapolis, MN

2 Stellent, Inc. Fiscal Year End March (in thousands) Fiscal Year Jun-05 Sep-05 Dec-05 Mar-06 Fiscal Year Jun-06 Sep-06 Dec-06 Mar-07 Fiscal Year Fiscal Year 2005A Q1A Q2 A Q3 A Q Q1 Q2 E Q3 E Q4 E 2007E 2008E Software 54,376 13,728 13,321 14,176 15,725 56,950 14,353 15,268 15,515 15,767 60,903 66,993 Post-Contract Support 32,663 9,673 9,888 9,904 10,134 39,599 10,310 10,319 11,169 11,635 43,432 47,775 Consulting Services 19,772 5,160 6,938 7,622 7,116 26,836 7,679 7,787 8,068 8,356 31,890 35,079 TotalRevenue 106,811 28,561 30,147 31,702 32, ,385 32,342 33,374 34,751 35, , ,848 Cost of Goods Sold Cost of Software Licenses 5,017 1, , , ,405 3,350 Amortized Software from Acquisitions 2, , ,238 1,340 Cost of Services 6,831 6,706 13,537 6,803 6,930 7,180 7,437 28,351 29,817 Cost of PCS 24,900 6,875 8,440 1,747 1,716 18,778 1,725 1,780 1,921 2,007 7,433 7,644 Total Cost of Goods Sold 32,307 8,451 9,698 10,315 9,616 38,080 9,663 9,829 10,287 10,648 40,427 42,151 Gross Profit 74,504 20,110 20,449 21,387 23,359 85,305 22,679 23,545 24,464 25,110 95, ,697 Operating Expenses Sales & Marketing 42,365 11,436 11,332 11,282 12,357 46,407 11,758 12,181 12,163 12,158 48,260 52,072 G & A 14,097 3,170 2,812 3,208 3,092 12,282 3,096 3,337 3,301 3,272 13,007 13,861 R&D 17,958 4,656 4,895 5,010 5,592 20,153 5,218 5,256 5,386 5,364 21,225 23,226 Amort. Of Acq. Intangible Assets 93 Total Operating Expenses 74,420 19,262 19,039 19,500 21,041 78,842 20,165 20,775 20,851 20,793 82,584 89,159 Operating Income ,410 1,887 2,318 6,463 2,514 2,770 3,613 4,317 13,214 18,538 EBITDA 5,621 1,965 2,599 3,693 3,981 12,238 4,004 4,157 4,920 5,558 18,639 20,743 Other Income (expenses) , ,096 3,000 One-Time Items (& 2007 Option Expense) (6,568) (181) (1,238) (195) (515) (2,129) (1,100) (667) (695) (715) (3,178) (2,500) Pretax Income (5,841) 1, ,282 2,501 6,515 2,163 2,848 3,700 4,421 13,132 19,038 Income Tax Tax Rate 0% 0% 14% 3% 0% 3% 3% 5% 4% 4% 4% 4% Net Income (5,841) 1, ,212 2,491 6,342 2,100 2,708 3,550 4,246 12,604 18,288 Diluted Shares Outstanding 27,180 28,487 29,264 30,103 30,851 29,676 31,154 31,500 32,000 32,000 31,664 32,500 Fully Diluted EPS (GAAP) (0.21) Proforma EPS Page2 8/7/06

3 Analyst Certification I, Richard A. Ryan, certify that the views expressed in this research report accurately reflect my personal views about the subject company and its securities. I also certify that I have not been, am not, and will not be receiving direct or indirect compensation related to the specific recommendations expressed in this report. Important Disclosures: The analyst or any member of his/her household does not hold a long or short position, options, warrants, rights or futures of this security in their personal account(s). As of the end of the month preceding the date of publication of this report, Feltl and Company did not beneficially own 1% or more of any class of common equity securities of the subject company. There is not any actual material conflict of interest that either the analyst or Feltl and Company is aware of. The analyst has not received any compensation for any investment banking business with this company in the past twelve months and does not expect to receive any in the next three months. Feltl and Company has not been engaged for investment banking services with the subject company during the past twelve months and does not anticipate receiving compensation for such services in the next three months. Feltl and Company has not served as a broker, either as agent or principal, buying back stock for the subject company s account as part of the company s authorized stock buy-back program in the last twelve months. No director, officer or employee of Feltl and Company serves as a director, officer or advisory board member to the subject company. Feltl and Company Rating System: Feltl and Company utilizes a four tier rating system for potential total returns over the next 12 months. Strong Buy: The stock is expected to have total return potential of at least 30%. Catalysts exist to generate higher valuations, and positions should be initiated at current levels. Buy: The stock is expected to have total return potential of at least 15%. Near term catalysts may not exist and the common stock needs further time to develop. Investors requiring time to build positions may consider current levels attractive. Hold: The stock is expected to have total return potential of less than 15%. Fundamental events are not present to make it either a Buy or a Sell. The stock is an acceptable longer-term holding. Sell: Expect a negative total return. Current positions may be used as a source of funds. Page3 8/7/06

4 8/1/2006 Ratings Distribution for Feltl and Company Investment Banking Number of Percent Number of Percent of Rating Stocks of Total Stocks Rating category SB/Buy 25 71% 5 20% Hold 9 26% 0 0% Sell 1 3% 0 0% % 5 14% The above represents our ratings distribution on the stocks in the Feltl and Company research universe, together with the number in (and percentage of) each category for which Feltl and Company provided investment-banking services in the previous twelve months. 11/16/04 Buy Target: $ /21/05 Buy Target: $ /16/05 Buy Target: $ /09/05 Buy Target: $ /04/05 Hold Target: $ /08/06 Buy Target: $ /16/06 Buy Target: $13.00 Date Nature of Report Rating Price Target 11/16/04 Coverage Initiated Buy $ /16/05 Target Reduced Buy $ /09/05 Price Target Raised Buy $ /04/05 Q2 Reported Hold $ /08/06 Great Q3! Upgrading to BUY Buy $ /16/06 Fiscal 2006 Results Buy $ /7/06 Q Results Buy $14.00 Feltl and Company does make a market in the subject security at the date of publication of this report. As a market maker, Feltl and Company could act as principal or agent with respect to the purchase or sale of those securities. Page4 8/7/06

5 Valuation and Price Target Methodology: We are maintaining our price target of $14. This represents 17x our fiscal 2008 EPS estimate of $0.68, plus cash. This multiple approximates our estimated EPS growth rate for STEL. While STEL s relative valuations appear higher-than-average in the content management space, Stellent also seems positioned to grow its profits and cash flows faster than its peers. In addition, a premium-priced acquisition is always a possibility. Risks to Achievement of Estimates and Price Target: We believe that Stellent faces three general types of risks: competition risk, acquisition risk, and valuation risk. Competition Risk: With the exception of a few large companies, who have established the standards within an industry, software is a very competitive industry. Because the marginal costs for software licenses tend to be very low, software companies sometimes have the incentive to cut prices significantly in attempts to secure market share. This competitive situation exists even if the industry is dominated by a small number of companies. Therefore, pricing tends to stabilize at the point where only the most efficient companies make profits. The less efficient companies, which tend to be smaller companies, often become stuck with perpetual losses unless they can find a less-competitive niche. Stellent will continue to operate in this generally competitive environment for the foreseeable future. While average selling prices have stayed firm to date, they may come under pressure in the future. Alternatively, Stellent may be forced to significantly increase sales and marketing expenses in order to win future deals. Acquisition Risk: The Enterprise Content Management market is consolidating as the smaller software firms are being acquired by larger firms, including software companies, hardware companies, or diversified technology companies. Because Stellent is one of the smaller, public, software firms remaining in this market, a larger firm may attempt to acquire its shares. The terms of such an acquisition may or may not be favorable to Stellent s existing shareholders. Valuation Risk: Even if Stellent meets or exceeds our expectations in terms of revenues, earnings, and cash flow, investors may not be willing to pay as high a valuation as assumed in setting our price target. Also, Stellent has historically reported income on a proforma and tax-free basis. To the degree that investors focus on these numbers, they may be disappointed with the apparent earnings growth as the Company transitions to pure GAAP reporting on a taxable basis. Due to a combination of substantial net operating loss (NOL) carry-forwards, and a history of losses, we believe that Stellent will continue to report earnings on a tax-free basis for the next four to six quarters. Readers should recognize that the risks outlined above do not represent a comprehensive list of all risk factors that may impact the achievement of our price target. Other Disclosures: The information contained in this report is based on sources considered to be reliable, but not guaranteed, to be accurate or complete. Any opinions or estimates expressed herein reflect a judgment made as of this date, and are subject to change without notice. This report has been prepared solely for informative purposes and is not a solicitation or an offer to buy or sell any security. The securities described may not be qualified for purchase in all jurisdictions. Because of individual requirements, advice regarding securities mentioned in this report should not be construed as suitable for all accounts. This report does not take into account the investment objectives, financial situation and needs of any particular client of Feltl and Company. Some securities mentioned herein relate to small speculative companies that may not be suitable for some accounts. Feltl and Company suggests that prior to acting on any of the recommendations herein, the recipient should consider whether such a recommendation is appropriate given their investment objectives and current financial circumstances. Past performance does not guarantee future results. Additional information is available upon request. Page5 8/7/06

6 EQUITY CAPITAL MARKETS DIRECTORY RESEARCH DEPARTMENT Clinton H. Morrison, CFA Director of Equity Research (612) Ernest W. Andberg, CFA (612) INSTITUTIONAL SALES: (866) Thomas Pierce Senior Vice President Institutional Sales (612) Mark Hagen (612) Richard A. Ryan (612) Jack M. Zipoy (612) TRADING: (866) Joseph G. Fredericks Manager, Equity Trading (612) William W. Koop (612) Thomas Walters (612) Elliott Randolph Institutional Sales Trading (612) Deborah L. Zieman Institutional Sales Trading (612) Luke J. Weimerskirch Institutional Sales Trading (612) Ryan Quade (612) Jo Pihl (612) Jimmy Sioris (612) SOUTH SIXTH STREET SUITE 4200 MINNEAPOLIS, MINNESOTA (612) (866) MEMBER SIPC & NASD

Astronics Corporation (ATRO - $16.35) Coverage terminated.

Astronics Corporation (ATRO - $16.35) Coverage terminated. Richard A. Ryan raryan@feltl.com (612) 492-8841 Aerospace Supplier May 12, 2008 Financial Summary Rev(mil) 2007 2008E 2009 Mar $ 42.9 $ 41.1 - Jun $ 41.4 - Sep $ 37.7 - Dec $ 36.3 - FY $158.2 P/Sales 0.8x

More information

Micro Component Technology (MCTI - $0.43) Q4 Results Below Estimates Key Points:

Micro Component Technology (MCTI - $0.43) Q4 Results Below Estimates Key Points: Richard A. Ryan raryan@feltl.com (612) 492-8841 Semiconductor Cap. Equipment February 17, 2005 Financial Summary Rev(mil) 2003 2004 2005E Mar $ 2.2 $ 4.3 $2.3E Jun $ 2.3 $ 4.2 $2.8E Sep $ 2.9 $ 3.9 $3.5E

More information

Domino s Pizza, Inc.

Domino s Pizza, Inc. Feltl and Company Research Department 225 South Sixth Street, Suite 4200 Minneapolis, MN 55402 1.866.655.3431 Mark E. Smith mesmith@feltl.com 612.492.8806 Domino s Pizza, Inc. Company Description: Domino

More information

(DAKT - - $16.12) 26, 2003 DAKT

(DAKT - - $16.12) 26, 2003 DAKT Dennis Nielsen denielsen@feltl.com (612) 492-8806 Consumer Products - Durables August 26, 2003 Financial Summary Rev (mil) 2002 2003A 2004E July $40.2 $44.1 $48.9A Oct $41.6 $48.1 $54.8E Jan $30.9 $38.2

More information

Compex Technologies, Inc. (CMPX - $4.89)

Compex Technologies, Inc. (CMPX - $4.89) Ernest W. Andberg, CFA ewandberg@feltl.com (612) 492-8836 Medical Devices February 10, 2005 Financial Summary Rev(mil) 2004 2005E 2006E Sep $19.2 $21.7A $ Dec $22.5 $25.2A $ Mar $21.7 $24.6 $ Jun $22.7

More information

MINE SAFETY APPLIANCES CO. (MSA - $63.27) Q3 Better Than Expected BUY Aggressive

MINE SAFETY APPLIANCES CO. (MSA - $63.27) Q3 Better Than Expected BUY Aggressive Richard A. Ryan raryan@feltl.com (612) 492-8841 Safety Equipment Manufacturer November 6, 2003 Financial Summary Rev 2002 2003E 2004E (mil) March $128.1 $160.4A $175.1E June $141.9 $176.4A $192.0E Sept.

More information

American Vanguard (AVD - $25.01) STRONG BUY

American Vanguard (AVD - $25.01) STRONG BUY American Vanguard American Vanguard is a small but rapidly growing manufacturer and marketer of crop protection products like insecticides, herbicides, and fungicides for use by a variety of farmers. In

More information

Digi International, Inc.

Digi International, Inc. Feltl and Company Research Department 225 South Sixth Street, Suite 4200 Minneapolis, MN 55402 1.866.655.3431 Jay M. Meier jmmeier@feltl.com 612.492.8847 Digi International, Inc. Company Description: Digi

More information

Vascular Solutions, Inc.

Vascular Solutions, Inc. Vascular Solutions, Inc. Vascular Solutions is a medical device company focused on developing products for the interventional radiology and cardiology markets. Current product offerings include the Duett

More information

MEDNAX, Inc. Better than expected results inline with our propriety research; raising estimates

MEDNAX, Inc. Better than expected results inline with our propriety research; raising estimates MEDNAX, Inc. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN 55402 1.866.655.3431 Matt J. Weight mjweight@feltl.com 612.492.8812 Healthcare Services August 1,

More information

Hibbett Sports Inc. (HIBB - $50.89) BUY

Hibbett Sports Inc. (HIBB - $50.89) BUY Hibbett Sports Inc. Company Description: Hibbett Sports Inc. operates 848 sporting goods stores in the United States with most stores located in the Southeast. Hibbett is a full service sporting goods

More information

DexCom, Inc. (DXCM - $15.73) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

DexCom, Inc. (DXCM - $15.73) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN DexCom, Inc. Company Description: DexCom is a real-time diagnostics medical device company focused on the continuous glucose monitoring (CGM) market for both diabetics and critical care patients. The company

More information

DaVita Inc. (DVA - $119.21) BUY. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

DaVita Inc. (DVA - $119.21) BUY. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN DaVita Inc. Company Description: DaVita Inc. provides dialysis services for patients suffering from chronic kidney failure, which is known as end stage renal disease (ESRD) in the United States. Feltl

More information

DexCom, Inc. (DXCM - $14.30) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

DexCom, Inc. (DXCM - $14.30) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN DexCom, Inc. Company Description: DexCom is a real-time diagnostics medical device company focused on the continuous glucose monitoring (CGM) market for both diabetics and critical care patients. The company

More information

Vascular Solutions, Inc. (VASC - $9.21)

Vascular Solutions, Inc. (VASC - $9.21) Medical Devices March 23, 2005 Financial Summary Rev(mil) 2004 2005E 2006E Mar $4.4 $7.0E $ Jun $5.2 $7.6E $ Sep $5.9 $8.6E $ Dec $6.7 $9.9E $ FY $22.3 $33.0E $45.0E P/Sales 5.9x 4.0x 2.9x EPS 2004 2005E

More information

DexCom, Inc. Tickled pink Q3 EPS less red than our estimate and new G4 color choice

DexCom, Inc. Tickled pink Q3 EPS less red than our estimate and new G4 color choice DexCom, Inc. Company Description: DexCom is a real-time diagnostics medical device company focused on the continuous glucose monitoring (CGM) market for both diabetics and critical care patients. The company

More information

Kona Grill, Inc. (KONA - $11.28) Initiating Coverage Growth

Kona Grill, Inc. (KONA - $11.28) Initiating Coverage Growth Mark W. Moeller mwmoeller@feltl.com (612) 492-8849 Upscale Casual Restaurants September 30, 2005 Financial Summary Rev(mil) 2004A 2005E 2006E Mar $5.3 $8.0A $10.3E Jun $5.6 $8.9A $11.5E Sep $6.6 $9.0E

More information

MINE SAFETY APPLIANCES CO. (MSA - $47.98) Initiating Coverage BUY Aggressive

MINE SAFETY APPLIANCES CO. (MSA - $47.98) Initiating Coverage BUY Aggressive Richard A. Ryan raryan@feltl.com (612) 492-8841 Safety Equipment Manufacturer August 20, 2003 Financial Summary Rev 2002 2003E 2004E (mil) March $128.1 $160.4A $175.1E June $141.9 $175.9A $192.0E Sept.

More information

ALPHA SELECT LIST CAS Medical Systems, Inc.

ALPHA SELECT LIST CAS Medical Systems, Inc. A Matt G. Hewitt Senior Research Analyst 612-334-6314 matthew.hewitt@craig-hallum.com Lucas Baranowski Research Analyst 612-334-8224 lucas.baranowski@craig-hallum.com Charlie Eidson, CPA Research Analyst

More information

Bottomline Technologies Reconciliation to Non GAAP Measures Three Months Ended June 30, 2013

Bottomline Technologies Reconciliation to Non GAAP Measures Three Months Ended June 30, 2013 Reconciliation to Measures Three Months Ended June 30, 2013 Non Cash Amortization of Equity Based Integration Restructuring Interest GAAP Intangible Assets Compensation Related Expenses Expenses Expense

More information

Financial results & business update. Quarter and year ended 31 December February 2016

Financial results & business update. Quarter and year ended 31 December February 2016 Financial results & business update Quarter and year ended 31 December 2015 11 February 2016 Disclaimer 3 Any remarks that we may make about future expectations, plans and prospects for the company constitute

More information

OTC Markets Group Inc. (OTCM) NR Price Target: $30 Price: $29.80 Risk Rating: H. Sidoti & Company, LLC

OTC Markets Group Inc. (OTCM) NR Price Target: $30 Price: $29.80 Risk Rating: H. Sidoti & Company, LLC September 29, 2017 Company Sponsored Research Morning Meeting Note Raise Price Target; Raise Earnings Estimates OTC Markets Group Inc. (OTCM) Equity Research Raise Target To $30 (From $27) As We Introduce

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$20.47) Intraday Meeting Note NEUTRAL

More information

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29 April 19, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview OTC Markets Group Inc. (OTCM) Equity Research Forecast 10% EPS Growth In 1Q:18, Aided By Lower Taxes; View OTCM As Well Positioned

More information

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation July 13, 2018 Company Sponsored Research Morning Meeting Note Raise Price Target Sify Technologies Limited Sponsored ADR (SIFY) Equity Research We Raise Our Price Target To $4 (From $3); Think Strong Outlook

More information

ResMed, Inc. (RMD - $44.37) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

ResMed, Inc. (RMD - $44.37) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN ResMed, Inc. Company Description: ResMed develops, manufactures and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing (SDB) and other respiratory disorders.

More information

Synovis Life Technologies, Inc. (SYNO - $17.89) HOLD. Dennis E. Nielsen, CFA (612)

Synovis Life Technologies, Inc. (SYNO - $17.89) HOLD. Dennis E. Nielsen, CFA (612) Dennis E. Nielsen, CFA denielsen@feltl.com (612) 492-8806 Medical Devices June 2, 2003 Financial Summary Rev (mil) 2002 2003E 2004E Jan $8.0 $12.5A Apr $9.5 $15.3A Jul $10.7 $14.0E Oct $11.8 $14.5E FY

More information

Socket Mobile, Inc. (SCKT) NR Price Target: $6 Price: $4.04 Risk Rating: M. Sidoti & Company, LLC

Socket Mobile, Inc. (SCKT) NR Price Target: $6 Price: $4.04 Risk Rating: M. Sidoti & Company, LLC October 27, 2017 Company Sponsored Research Morning Meeting Note Earnings Release Socket Mobile, Inc. (SCKT) Equity Research Maintain $6 Price Target; Robust Demand From Application Developer, Despite

More information

ResMed, Inc. (RMD - $29.84) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN

ResMed, Inc. (RMD - $29.84) HOLD. Feltl and Company Research Department 2100 LaSalle Plaza 800 LaSalle Avenue Minneapolis, MN ResMed, Inc. Company Description: ResMed develops, manufactures and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing (SDB) and other respiratory disorders.

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive January 23, 2019 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 TowerJazz (TSEM-NASDAQ)

More information

LifeVantage Corp. NasdaqCM: LFVN

LifeVantage Corp. NasdaqCM: LFVN LifeVantage Corp. NasdaqCM: LFVN New Products and Valuation Outweigh issues in Japan, reiterate Strong Buy LifeVantage Corp (LFVN) focuses on selling healthy living products through direct selling. They

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC February 28, 2019 Intraday Note Lower Earnings Estimates; Earnings Release AAON, Inc. (AAON) Equity Research 4Q:18 Revenue Beats, But EPS Misses On Soft Gross Margin; Although Backlog Supports Growth,

More information

Financial and Operating Results. Second Quarter and First Half 2016

Financial and Operating Results. Second Quarter and First Half 2016 Financial and Operating Results Second Quarter and First Half 2016 August 2016 Safe Harbor Statement Forward Looking Statements In addition to historical information, this earnings presentation contains

More information

4Q 2016 Earnings Webcast. Solutions that Protect and Promote the World s Great Brands

4Q 2016 Earnings Webcast. Solutions that Protect and Promote the World s Great Brands 4Q 2016 Earnings Webcast Solutions that Protect and Promote the World s Great Brands Net Sales (US$ millions) $500 $1,900 $1,835.2 $450 $1,800 $1,738.6 $1,741.6 $1,700 $400 $379.8 $373.8 $379.8 $373.8

More information

Q Financial Supplement

Q Financial Supplement Reconcilation of GAAP and Non-GAAP Financial Measures Non-GAAP Net Income and Non-GAAP EPS (in thousands except per share data) 2014 2015 Three Months Ending June 30, Low Range Guidance (1) High Range

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC November 1, 2018 Intraday Note Raise Earnings Estimates; Earnings Release AAON, Inc. (AAON) Equity Research Increase 2019 EPS Estimate After This Morning s Solid 3Q:18 Report; 3Q:18 EPS Of $0.27 Beat Our

More information

CalAmp Corp. CAMP - $ NASDAQ Buy

CalAmp Corp. CAMP - $ NASDAQ Buy Scott W. Searle, CFA, (646) 616-2782 ssearle@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH June 28, 2018 Technology: Communications, Wireless & IoT CalAmp Corp. CAMP

More information

RPC GROUP PLC 2017 / 18 RESULTS

RPC GROUP PLC 2017 / 18 RESULTS RPC THE ESSENTIAL INGREDIENT RPC GROUP PLC 2017 / 18 RESULTS Supplemental Information 1 2018 RPC Group Plc. All Rights Reserved. Key figures Sales ( m) +36% Adjusted Operating Profit ( m) +38% Adjusted

More information

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit EQUITY RESEARCH QUARTERLY UPDATE July 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $300.00 ORLY - NASDAQ $277.51 3-5 Yr. EPS Gr. Rate 18% 52-Wk Range $284.66-$225.12 Shares Outstanding 99.4M

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$27.84) Morning Meeting Note NEUTRAL

More information

Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time

Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time April 27, 2018 Company Sponsored Research Morning Meeting Note Lower Price Target; Lower Earnings Estimates Socket Mobile, Inc. (SCKT) Equity Research Lower Price Target To $4 (From $6); Near-Term Trends

More information

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016 EQUITY RESEARCH QUARTERLY UPDATE September 22, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $900.00 AZO - NYSE $751.45 3-5 Yr. EPS Gr. Rate 14% 52-Wk Range $819.54-$681.01 Shares Outstanding 30.8M

More information

Fiscal 2015 Year End Financial Results. September 9, 2015

Fiscal 2015 Year End Financial Results. September 9, 2015 Fiscal 2015 Year End Financial Results September 9, 2015 Safe Harbor Statement Certain statements herein constitute forward-looking statements within the meaning of the Securities Act of 1933, as amended

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$26.20) Morning Meeting Note NEUTRAL

More information

Medifast, Inc. Top line still not taking shape, reiterate Neutral rating and decrease 2015 estimates. NYSE: MED

Medifast, Inc. Top line still not taking shape, reiterate Neutral rating and decrease 2015 estimates. NYSE: MED Medifast, Inc. NYSE: MED Top line still not taking shape, reiterate Neutral rating and decrease 2015 estimates. Medifast engages in the production, distribution, and sale of weight loss and weight loss

More information

TD AMERITRADE HOLDING CORPORATION CONSOLIDATED STATEMENTS OF INCOME In thousands, except per share amounts (Unaudited)

TD AMERITRADE HOLDING CORPORATION CONSOLIDATED STATEMENTS OF INCOME In thousands, except per share amounts (Unaudited) CONSOLIDATED STATEMENTS OF INCOME In thousands, except per share amounts Revenues: Transaction-based revenues: Commissions and transaction fees $ 301,272 $ 309,388 $ 265,442 $ 610,660 $ 552,555 Asset-based

More information

Results for Q4 FY2014 (Quarter Ended March 31, 2014) Earnings Announcement: April 30, 2014

Results for Q4 FY2014 (Quarter Ended March 31, 2014) Earnings Announcement: April 30, 2014 Results for Q4 FY2014 (Quarter Ended March 31, 2014) Earnings Announcement: April 30, 2014 Risks and Non-GAAP Disclosures This presentation contains forward-looking statements, which are based on current

More information

PARKERVISION, INC. Rating: BUY Target: $27. NASDAQ: PRKR - $12.66 Semiconductors Integrated Circuits

PARKERVISION, INC. Rating: BUY Target: $27. NASDAQ: PRKR - $12.66 Semiconductors Integrated Circuits EGE INSTITUTIONAL RESEARCH REPORT RESEARCH UPDATE MAY 3, 2007 PARKERVISION, INC. NASDAQ: PRKR - $12.66 Semiconductors Integrated Circuits PRKR Announced A $25 Million Licensing Agreement With ITT Corp

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $34 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $34 Price: $ Sidoti & Company, LLC December 16, 2016 Morning Meeting Note Raise Price Target AAON, Inc. (AAON) Equity Research Raise Target To $34 (From $28) On Anticipation Of A Lower Tax Rate; Continue To Forecast Strong Growth In 2017-2018;

More information

Calgon Carbon Corporation Rating: Hold

Calgon Carbon Corporation Rating: Hold WATER COMPANIES Christopher Bamman 212-218-3989 cbamman@morganjoseph.com Richard S. Paget, CFA 212-218-3894 rpaget@morganjoseph.com Company Update / Estimates Change February 25, 2008 Key Metrics CCC -

More information

Elbit Systems Ltd. Stock Price Performance. Source: Reuters All figures in US dollars, unless otherwise stated

Elbit Systems Ltd. Stock Price Performance. Source: Reuters All figures in US dollars, unless otherwise stated Equity Research Earnings Update March 14, 2007 Stock Rating: Sector Performer Sector Weighting: Market Weight 12-18 mo. Price Target $36.00 ESLT-OTC (3/14/07) $33.60 Key Indices: NASDAQ 3-5-Yr. EPS Gr.

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research December 15, 2017 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 icad Inc (ICAD-NASDAQ) ICAD: Study Shows IORT Superior

More information

BTO: Q2/15 Earnings Preview

BTO: Q2/15 Earnings Preview B2Gold Corp. (BTO-T: C$1.69), (BTG-N: US$1.31) August 13, 2015 BUY, High Risk Dundee target: C$2.75 BTO: Q2/15 Earnings Preview Joseph Fazzini, CPA, CA, CFA / (647) 428-8248 jfazzini@dundeecapitalmarkets.com

More information

THIRD QUARTER FISCAL YEAR 2018 FINANCIAL RESULTS. February 1, 2018

THIRD QUARTER FISCAL YEAR 2018 FINANCIAL RESULTS. February 1, 2018 THIRD QUARTER FISCAL YEAR 2018 FINANCIAL RESULTS February 1, 2018 CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT This presentation and discussion contains certain forward-looking

More information

Equity Research. Rockwell Collins, Inc. COL: Reduce FQ1 For Higher Restructuring; Savings To Offset. Outperform. November 16, 2015

Equity Research. Rockwell Collins, Inc. COL: Reduce FQ1 For Higher Restructuring; Savings To Offset. Outperform. November 16, 2015 November 16, 2015 Equity Research Rockwell Collins, Inc. COL: Reduce FQ1 For Higher Restructuring; Savings To Offset Summary. Rockwell Collins announced after the close on November 13 that its expected

More information

NxStage Medical, Inc.

NxStage Medical, Inc. NxStage Medical, Inc. Company Description: NxStage Medical, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of kidney failure, fluid

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$26.55) Morning Meeting Note NEUTRAL

More information

Small-Cap Research. TowerJazz (TSEM-NASDAQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. TSEM: 2017 on Track, Capacity Plans Need to Be Addressed By Year End

Small-Cap Research. TowerJazz (TSEM-NASDAQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. TSEM: 2017 on Track, Capacity Plans Need to Be Addressed By Year End Small-Cap Research May 9, 217 Lisa Thompson lthompson@zacks.com www.zacks.com 1 S. Riverside Plaza, Suite 16, Chicago, IL 666 TowerJazz (TSEM-NASDAQ) TSEM: 217 on Track, Capacity Plans Need to Be Addressed

More information

Welcome to Avnet s First Quarter Fiscal Year 2011 Teleconference and Webcast

Welcome to Avnet s First Quarter Fiscal Year 2011 Teleconference and Webcast Welcome to Avnet s First Quarter Fiscal Year 2011 Teleconference and Webcast October 28, 2010 2:00 p.m. Eastern Time 1 Accelerating Your Success Safe Harbor Statement This presentation contains certain

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $35 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $35 Price: $ Sidoti & Company, LLC September 15, 2017 Morning Meeting Note Company Update AAON, Inc. (AAON) Equity Research We Maintain Our Outlook For Robust Growth For AAON, Following A Peer s Positive Commentary Earlier This Week; Maintain

More information

SECOND QUARTER FISCAL YEAR 2019 FINANCIAL RESULTS. October 31, 2018

SECOND QUARTER FISCAL YEAR 2019 FINANCIAL RESULTS. October 31, 2018 SECOND QUARTER FISCAL YEAR 2019 FINANCIAL RESULTS October 31, 2018 CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT This presentation and discussion contains certain forward-looking

More information

Results for Q1 Fiscal 2018

Results for Q1 Fiscal 2018 Results for Q1 Fiscal 2018 Earnings Announcement: July 27, 2017 (Quarter Ending June 30, 2017) Risks and Non-GAAP Disclosures This presentation contains forward-looking statements, which are based on current

More information

Allscripts Healthcare Solutions, Inc.

Allscripts Healthcare Solutions, Inc. HEALTHCARE: Healthcare Technology Company Update / Estimates Change Allscripts Healthcare Solutions, Inc. MDRX: Continuing the String of Bookings We reiterate our SW rating on Allscripts (MDRX) due to

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive July 5, 2018 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Medical Transcription

More information

AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving

AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving Consumer: Automotive Retail AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving Maintaining SW: 1) auto retail industry growth outlook remains

More information

Darden Restaurants, Inc.

Darden Restaurants, Inc. Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because

More information

REXNORD Third Quarter Fiscal Year 2017 Financial Results. February 2, 2017

REXNORD Third Quarter Fiscal Year 2017 Financial Results. February 2, 2017 REXNORD Third Quarter Fiscal Year 2017 Financial Results February 2, 2017 Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion contains certain forward-looking

More information

Albemarle Corporation Second Quarter 2017 Earnings Appendix & Non-GAAP Reconciliations Conference Call/Webcast Tuesday, August 8 th, :00am ET

Albemarle Corporation Second Quarter 2017 Earnings Appendix & Non-GAAP Reconciliations Conference Call/Webcast Tuesday, August 8 th, :00am ET Albemarle Corporation Second Quarter 2017 Earnings Appendix & Non-GAAP Reconciliations Conference Call/Webcast Tuesday, August 8 th, 2017 9:00am ET Forward-Looking Statements Some of the information presented

More information

CDW Corporation. Webcast Conference Call May 4, CDW.com

CDW Corporation. Webcast Conference Call May 4, CDW.com CDW Corporation Webcast Conference Call May 4, 2016 CDW.com 800.800.4239 Today's Agenda 1st Quarter Results Key Performance Drivers and Strategic Progress Financial Results Outlook Q&A 1 Disclaimers This

More information

Barco N.V. Cinema Drives Top-Line Beat; Healthcare and Enterprise Behind EBITDA Expansion

Barco N.V. Cinema Drives Top-Line Beat; Healthcare and Enterprise Behind EBITDA Expansion EQUITY RESEARCH COMPANY UPDATE February 10, 2017 Stock Rating: PERFORM 12-18 mo. Price Target NA BAR.BR - BRU 80.49 3-5 Yr. EPS Gr. Rate 3% 52-Wk Range 82.28-54.10 Shares Outstanding 12.5M Float 8.6M Market

More information

PARKERVISION, INC. Rating: STRONG BUY Target: $27. NASDAQ: PRKR - $15.75 Semiconductors Integrated Circuits

PARKERVISION, INC. Rating: STRONG BUY Target: $27. NASDAQ: PRKR - $15.75 Semiconductors Integrated Circuits EGE INSTITUTIONAL RESEARCH REPORT RESEARCH UPDATE DECEMBER 24, 2007 PARKERVISION, INC. NASDAQ: PRKR - $15.75 Semiconductors Integrated Circuits PRKR Signs First Mobile Handset Deal; Upgrading To STRONG

More information

Digital River, Inc. Second Quarter Results (Unaudited, in thousands) Subject to reclassification

Digital River, Inc. Second Quarter Results (Unaudited, in thousands) Subject to reclassification (Unaudited, in thousands) Condensed Consolidated Balance Sheets As of December 31, 2008 2007 Assets: Current assets Cash and cash equivalents $ 276,927 $ 381,788 Short-term investments 201,297 315,636

More information

2018 Second Quarter Earnings Call. May 8, 2018

2018 Second Quarter Earnings Call. May 8, 2018 2018 Second Quarter Earnings Call May 8, 2018 Forward Looking Statements / Non-GAAP Measures This presentation contains information about management's view of the Company's future expectations, plans and

More information

Sterling Construction Company, Inc. Rating: Hold

Sterling Construction Company, Inc. Rating: Hold ENGINEERING & CONSTRUCTION Richard S. Paget, CFA 212-218-3894 rpaget@morganjoseph.com Christopher Bamman 212-218-3989 cbamman@morganjoseph.com Company Update / Estimates Change May 11, 2006 Key Metrics

More information

Appendix. Non-GAAP Adjustments

Appendix. Non-GAAP Adjustments Appendix Non-GAAP Adjustments Reconciliation of Reported (GAAP) to Adjusted (non GAAP) Financial Measures (Dollar amounts in millions, except per share data) 00 006 007 008 009 3 00 0 4 0 03 6 04 7 0 8

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$23.39) Morning Meeting Note NEUTRAL

More information

Q Financial Results. July 22, 2010

Q Financial Results. July 22, 2010 Q2 2010 Financial Results July 22, 2010 Q2 2010 Non-GAAP Results Q2 10 Q2 09 Y/Y % growth Q1 10 Billings (1) $90M $69M 31% $79M Revenue $76M $61M 24% $70M Non-GAAP Gross Margin (%) (2) 74% 74% -- 73% Non-GAAP

More information

LoopNet. $28 $26 $24 $22 $20 $18 $16 $14 $12 $10 Jun-06 Sep-06 Dec-06 Mar-07 Jun-07

LoopNet. $28 $26 $24 $22 $20 $18 $16 $14 $12 $10 Jun-06 Sep-06 Dec-06 Mar-07 Jun-07 July 31, 2007 Analyst Highlights Street Estimates Recommendation: BUY 2006A 2007E 2008E Current Price: $21.01 EPS $0.40 $0.48 $0.59 Target Price: $25.00 P/E 52.5 43.8 35.6 Forecast Stock Return: 19.0%

More information

Albemarle Corporation Second Quarter 2018 Earnings and Non-GAAP Reconciliations Conference Call/Webcast Wednesday, August 8 th, :00am ET

Albemarle Corporation Second Quarter 2018 Earnings and Non-GAAP Reconciliations Conference Call/Webcast Wednesday, August 8 th, :00am ET Albemarle Corporation Second Quarter 2018 Earnings and Non-GAAP Reconciliations Conference Call/Webcast Wednesday, August 8 th, 2018 9:00am ET Forward-Looking Statements Some of the information presented

More information

Industry Overview February 16, 2010

Industry Overview February 16, 2010 Industry Overview February 16, 2010 Enterprise Software Brendan Barnicle 503.727.0624 bbarnicle@pacific-crest.com Matthew Coss 503.727.0622 mcoss@pacific-crest.com With Expectations Reset, Time to Add

More information

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy Equity Research Information Technology Mar 29, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$24.7 Strong earnings recovery ahead amid continued revenue momentum; maintain Buy FY1 results in

More information

Income from Operations

Income from Operations CONSOLIDATED INCOME STATEMENT (UNAUDITED) For the Three Months Ended June 30, 2007, 2006 and March 31, 2007 Except for Per Share Amounts and Shares Outstanding 3 months ended 3 months ended Jun. 30, 2007

More information

Financial results & business update. Quarter ended 30 September October 2016

Financial results & business update. Quarter ended 30 September October 2016 Financial results & business update Quarter ended 30 September 2016 19 October 2016 Disclaimer 3 Any remarks that we may make about future expectations, plans and prospects for the company constitute forward-looking

More information

Assuming Coverage with HOLD Rating PT$10.50 Waiting on Wireless Growth Oppty

Assuming Coverage with HOLD Rating PT$10.50 Waiting on Wireless Growth Oppty Digi International Digi International Inc. provides machine to machine (M2M) networking solutions that enable the connection, monitoring, and control of local or remote physical assets by electronic means.

More information

FOURTH QUARTER FISCAL YEAR May 18, 2017

FOURTH QUARTER FISCAL YEAR May 18, 2017 FOURTH QUARTER FISCAL YEAR 2017 FINANCIAL RESULTS May 18, 2017 CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT This presentation and discussion contains certain forward looking

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Jan 12, 2018 Page 1 OF 5 JPMorgan Chase is one of world's largest diversified banking firms. The company operates a leading global corporate and investment bank and is the second-largest

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION J.P. MORGAN ULTIMATE SERVICES CONFERENCE NOVEMBER 15, 2016 THE NASDAQ STRATEGY AND STORY Leveraging Our Technology and Our Relationships Across Global Capital Markets 2 PROFITABLE

More information

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30% Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May- Jun-16 Jul-16 Aug-16 Aug-16 Sep-16 Oct-16. Volume No.. I Issue No. 95 Dewan Housing Finance Corporation (DHFL) Nov. 4, 2016 BSE Code: 511072 NSE Code: DHFL

More information

Stryker Corp. Post-4Q15 Thoughts

Stryker Corp. Post-4Q15 Thoughts EQUITY RESEARCH QUARTERLY UPDATE January 27, 2016 Stock Rating: PERFORM 12-18 mo. Price Target $104.00 SYK - NYSE $96.02 3-5 Yr. EPS Gr. Rate 9% 52-Wk Range $105.34-$86.68 Shares Outstanding 378.4M Float

More information

The Medicines Company Model Update; Busy Catalyst Calendar Ahead

The Medicines Company Model Update; Busy Catalyst Calendar Ahead EQUITY RESEARCH QUARTERLY UPDATE March 23, 2016 Stock Rating: PERFORM 12-18 mo. Price Target NA MDCO - NASDAQ $31.48 3-5 Yr. EPS Gr. Rate NA 52-Wk Range $43.79-$25.27 Shares Outstanding 68.9M Float 67.1M

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 21, 2018 M. Marin 312-265-9211 mmarin@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Legacy Education Alliance, Inc.

More information

Safe Harbor and Non-GAAP Measures

Safe Harbor and Non-GAAP Measures Safe Harbor and Non-GAAP Measures Forward-Looking Statements This presentation contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements

More information

FIRSTSERVICE INVESTOR PRESENTATION. October 14, 2004

FIRSTSERVICE INVESTOR PRESENTATION. October 14, 2004 FIRSTSERVICE INVESTOR PRESENTATION October 14, 2004 Forward-Looking Statements Some of the information contained herein is forward-looking or time sensitive. FirstService Corporation undertakes no obligation

More information

Allscripts Healthcare Solutions, Inc.

Allscripts Healthcare Solutions, Inc. December 01, 2014 Allscripts Healthcare Solutions, Inc. Current Recommendation Prior Recommendation SUMMARY DATA NEUTRAL Outperform Date of Last Change 05/17/2012 Current Price (11/28/14) $12.02 Target

More information

FINANCIAL RESULTS AND COMPANY OVERVIEW Second-Quarter Performance

FINANCIAL RESULTS AND COMPANY OVERVIEW Second-Quarter Performance FINANCIAL RESULTS AND COMPANY OVERVIEW 08 Second-Quarter Performance September 5 th, 08 Disclaimer Forward-Looking Statements and Preliminary Results This presentation includes forward-looking statements

More information

CITY OF LONDON INVESTMENT GROUP

CITY OF LONDON INVESTMENT GROUP 21 January 2019 Financial Services Daily CLIG.L Line, CLIG.L, Trade Price(Last), 21/01/2019, 384.20, +11.00, (+2.90%) 23/01/2017-21/01/2019 (LON) Price GBp CITY OF LONDON INVESTMENT GROUP F M A M J J A

More information

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research Railways and T&D driving inflows November 23, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,055 Target Price Rs1,230

More information

William Blair Growth Stock Conference June 15, Member FINRA/SIPC

William Blair Growth Stock Conference June 15, Member FINRA/SIPC William Blair Growth Stock Conference June 15, 2011 Member FINRA/SIPC Safe Harbor Disclosure The following information contains forward-looking statements. Forward-looking statements include statements

More information

Small-Cap Research. Integral Technologies, Inc. (ITKG-OTC) ITKG: Upcoming Revenue Catalysts OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Integral Technologies, Inc. (ITKG-OTC) ITKG: Upcoming Revenue Catalysts OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research November 24, 2015 M. Marin 312-265-9211 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Integral Technologies, Inc. (ITKG-OTC) ITKG: Upcoming Revenue Catalysts Current Recommendation

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Dec 29, 2011 Page 1 OF 5 United Technologies is an aerospace-industrial conglomerate whose portfolio includes Climate Control & Security (which now combines UTC Fire Security with Carrier),

More information